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A variety of plant lectins have been shown to bind to receptors on the surface of cells 
and in the case of some lymphocytes trigger these cells into new patterns of activity. 
The earliest of these to be studied was phytohemagglufinin (PHA) 1 (1). This material, 
which is obtained as an extract of beans (Phaseolus vulgaris), has affinity for the sugar 
residue N-acetyl D-galactosamine or the galactose penultimate to N-acetylneuraminic 
acid (2). Concanavalin A (Con A) (3), which is obtained from the jack bean (Canavalia 
ensiformis),  binds  to  a-D-mannopyranosyl,  a-  and  /~-D-glucopyranosyl, and  j3-D- 
fructofuranosyl groups (4-9). It has been shown to have a powerful mitogenic activity 
(I0, 11). Con A exists as a tetramer with four subunits of a molecular weight of 27,000 
with one saccharide binding site per monomer.  Other forms may exist and it is not 
clear which forms have biological activity (12).  Other plant mitogens include ricin, 
from  castor  beans,  which  binds  fl-D-galactopyranosyl residues  (13)  and  pokeweed 
mitogen (PWM), from Phytolacca americana, whose specificity is unknown. 
It has been shown  that viral-transformed cells are more readily agglutinated by 
various plant mitogens (14, 15). The change in agglutinability appears to be due to a 
change in the distribu'tion or accessibility  of the mitogen binding site rather than to an 
increase in the number of sites (16-18). The increased agglutinability correlates with a 
loss of contact inhibition (15).  Similar changes are observed when normal cells are 
treated with proteolytic enzymes  (19,  20)  or during mitosis (21).  The release from 
contact inhibition in  transformed cells can  be reversed by treatment with  trypsin- 
treated (monovalent) Con A (22). 
Treatment  of normal lymphoid cells with plant mitogens produces a  variety of 
effects. Although all these mitogens appear to bind to  the surface of all lymphoid 
cells in approximately equal amounts, their patterns of activity differ quite markedly 
(23,  24). Thymus-derived lymphocytes (T cells) of the mouse (23, 25, 26) and cells of 
the thymus medulla (27)  are stimulated to blast transformation, increased thymidine 
1Abbre~dations  used in  this paper: ATXBM,  adult,  thymectomized,  irradiated,  bone 
marrow-protected; B cells, bone marrow-  or bursa-derived lymphocytes; BSS, balanced  salt 
solution;  Con A, concanavalin  A; goat anti-BA thymus antigen, goat anti-brain-associated 
thymus antigen; PFC,  plaque-forming  cells; PHA,  phytohemagglutinin; PWM,  pokeweed 
mitogen;  SRBC,  sheep  red  blood  ceils;  T  cells,  thymus-derived lymphocytes; TdR-~H, 
tritiated thymidine; TNP, trinitrophenyl. 
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uptake, and cell division by PHA. Cells in the thymus cortex and bone marrow-derived 
cells do not respond although they have been shown to bind approximately the same 
amount of mitogen. There are on the order of l0  T Con A binding sites on all lymphoid 
cells and thymidine uptake is maximally stimulated when 16-25% of the Con A sites 
are bound (23). It has been claimed that PWM (25, 26), lipopolysaccharide  from Gram- 
negative bacteria (28),  and insoluble preparations of Con A  (29,  30)  stimulate bone 
marrow-derived cells to blast transformation and increased thymidine uptake directly 
in the absence of thymus-derived cells. Mitogen-stimulated lymphocytes have  also 
been shown to be stimulated to make a variety of products characteristic of thymus- 
derived lymphocytes. For example, it has been claimed that PHA-stimulated lympho- 
cytes produce lymphotoxin (31-33), and that Con A-stimulated lymphocytes produce 
migration inhibition factor (34, 35). PWM-, Con A-, or PHA-stimulated lymphocytes 
have  all been  shown  to  be cytotoxie to  labeled mouse fibroblast cultures  (36-38) 
although the mechanism of action of PWM may be different from that of the other 
two (38). 
The literature on the effect of plant mitogens on the immune response in vivo or in 
vitro  is  extensive but  conflicting. The bulk  of  the  evidence suggests  that  the  ad- 
ministration of mitogen is inhibitory to the response to antigen. Rich and Pierce (39) 
have recently demonstrated that Con A inhibits the immune response in the mitogenic 
concentration range but produces some stimulation at lower concentrations. Yahara 
and Edelman (40)  have shown that higher concentrations of Con A inhibit the "cap" 
formation induced in bone marrow-derived lymphoid cells (B cells) incubated with 
anti-immunoglobulin sera. 
We recently received a number of unpublished manuscripts from Doctors Anders- 
son, SjSberg, and M611er which described a  variety of experiments dealing with the 
effects of plant mitogens and bacterial endotoxins on the immune response. In one of 
these, now published, they have shown that Con A restored the immune response of 
mouse spleen cell suspensions from the thymus-deficient nude mice (41). We, therefore, 
decided to embark on a systematic study of the effect of plant mitogens on the response 
of mouse spleen cell suspensions to antigen in vitro in the hope that it would lead to 
some greater understanding of the mechanism of the triggering of B cells to prolifera- 
tion and antibody synthesis. 
We have been interested in the mechanism of T  cell-B cell interaction and the 
possibility that the helper effect of T  cells is mediated by a non-antigen-specific 
stimulatory  factor  that  acts  on  B  cells  (42,  43).  We  argued  that  the  plant 
mitogens must  either  act directly on  the  B  cell or must  trigger the T  cell to 
synthesize  and/or  release  the  hypothetical  thymus-derived  mediator,  which 
then  acts on the B  cell. In this paper we have clarified the nature of the con- 
flicting inhibitory and  stimulatory effects of Con  A  and  have  made  a  partial 
identification of the cell targets of Con A  action. 
Materials and Methods 
Animals. -BDF1  mice  (C57BL/6  female  X  DBA/2 male) were bred in our own colony. 
Adult thymectomized,  irradiated, bone marrow-restored  (ATXBM)  mice were also used. 
Antigens.-Sheep  erythrocytes (SRBC)  (Colorado Serum  Company, Denver, Colo.)  and RICHARD  W.  DUTTON  i447 
trinitropbenylated SRBC  (TNP-SRBC)  were prepared  by  the method  of' Rittenberg and 
Pratt (44) as modified by Kettman and Dutton (45). Concanavalin A, twice crystallized (code 
79-001, lot No. 41), was obtained from Miles-Yeda Ltd., Miles Laboratories, Inc., Kankakee, 
Ill. It was stored at 4°C. Substocks were thawed for use and refrozen. There was no indication 
of any loss or change in activity over 3-4 wk. Tritiated thymidine (TdR-3H)  was obtained 
from Schwarz Bio Research, Inc., Orangeburg, N,Y., at specific activity 11.3 Ci/mmole. 
Immunization. -Immunization for T cell priming was by injection of 0.2 ml of a 0.1% v/v 
SRBC  suspension in  the  tail  vein 3  days  before sacrifice  (46). In  vitro cultures received 
3 X  106 SRBC or 3 X  10  ~ TNP-SRBC/1 ml culture on day zero. 
Cultures. -Mouse spleen cell suspensions were cultured at 1 X  107 cells/ml (unless other- 
wise indicated) by the method of Mishell and Dutton  (47). Fetal bovine serum lot No. 722 
obtained from Reheis Co., Inc., Berkeley Heights, N.J., was used throughout. 
Cell Recoveries. -Cell suspensions were harvested at  the  end  of the  incubation period, 
centrifuged, and resuspended in balanced salt solution (BSS) for assay. Cell counts were ex- 
pressed as per cent of the cells present at the start of incubation. No correction was made for 
cell viability. Cell  viabilities were determined in some cases by trypan blue dye exclusion. 
Thymidine incorporation was measured by the addition of 0.1 ml of BSS containing 1 #Ci of 
TdR-3H in 0.5 #g of TdR. 
Goat Anti-Brain-Associated Thymus Antigen Serum (Goat Anti-BA  Thymus Antigen).- 
Spleen cells were treated with anti-BA thymus antigen serum and guinea pig complement 
sequentially to remove T  cells  (46).  The antiserum was prepared in goats as described by 
Golub (48). 10  s spleen cells in 2 ml of BSS (47) were incubated with 1.0 ml of a 1 : 18 dilution 
of antiserum in BSS for 30 rain at 37°C. The cells were then washed once and resuspended to 
the original  volume in BSS.  1 ml of guinea pig serum  (six times absorbed with spleen and 
thymus and once with heterologous erythrocytes) diluted 1:4 was added and incubated for 
30 rain at 37°C. The cells were then washed three times in BSS and resuspended in complete 
medium at  107/ml.  This treatment killed 95% of thymus cell suspensions at antiserum dilu- 
tions do~n to 1:30 and 30-40%  spleen cells between 1:10 and 1:60 dilution of antiserum. 
RESULTS 
The Effect of Concanavalin A  on Normal Spleen Cells.--Cell  suspensions from 
the spleens of normal mice were cultured at 1 X  107 cells/ml in the presence of 
3  X  106 SRBC.  Varying amounts of concanavalin A  (Con A)  were added  at 
zero time  and the number of direct  anti-SRBC  plaque-forming cells  (PFC's) 
was determined at day 4. The following points are illustrated in Fig.  1.  There 
was  a  marked depression  of  the  response  at  concentrations of  1-4  #g/ml  of 
Con A  with maximum inhibition at 2 #g/ml. At 8/~g/ml  there was less inhibi- 
tion. At concentrations above 8 #g/ml Con A again inhibited the response. This 
biphasic curve was seen in all of many experiments. It can be seen in Fig. 2 that 
the  response  to  the  hapten TNP  coupled  to  SRBC  as  carrier was  similarly 
affected by  Con A.  This  was  also true for the  anti-TNP  and  anti-SRBC  re- 
sponses of carrier-primed mice (injected with low doses of SRBC 3 days before 
sacrifice). 
Con A also has a marked effect on cell recovery (Figs. 1 and 2). In the control 
cultures the cell recovery represents 50% of cells present at the start of incuba- 
tion. This is increased in the presence of Con A  over the range of 1/~-4 #g/ml 
and  the  cell  recoveries have ranged  from 60  to  150%  of the initial  number. 
The  position  of  the  curve  of  increased  cell  recovery  corresponds  with  the 1448  EFFECTS  OF  CON  A  ON  TIlE  IlVIMUNE RESPONSE 
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FIG. 1. The effect of Con A on spleen cell suspensions from normal mice. The Con A was 
added at the concentrations  indicated at zero time (T =  0). All assays were made at day 4. 
O--O, the response to SRBC in PFC/culture; ~--A,  the cell recovery expressed as per cent 
of ceils present initially; O--O,  the incorporation  of thymidine-3H present during the last 
16 hr of culture (80-96 hr) expressed as cpm per culture. 
inhibitory effect on the PFC response, but is a somewhat broader, flatter curve. 
The  increased cell  recovery is presumably the  consequence  of  the  mitogenic 
properties of Con A  and  the uptake  of thymidineJH is also increased in  the 
same concentration range (Fig. 1). At higher Con A concentrations, correspond- 
ing to the second range of inhibition of the PFC response there is a marked fall 
in cell recovery to levels below that seen in the control cultures and an inhibition 
of  thymidine-3H uptake.  Cell viabilities were  measured  in  three  consecutive 
experiments and the percentage of dye-excluding cells was significantly lower 
in the Con A-stimulated cultures (Table I) and the total number of viable cells 
was no  different from  that  in the control. Qualitative examination of stained 
preparations showed a marked increase in the number of blast cells in the Con 
A-stimulated cultures. 
Kinetics of PFC Response in the Presence of Con A.---The inhibitory effect of 
Con A  added at time zero becomes more marked with time and the increase in 
cell recovery becomes dramatic only on day 4. The effect of the time of addition RICHARD  W.  DUTTON  1449 
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FIG.  2. The effect of Con J  on the response to hapten and carrier antigen.  Spleen cell 
suspensions from normal mice were  incubated with  the indicated  concentrations of Con A 
added to T  =  0. All assays were made at day 4.  ©--O, anti-SRBC PFC/culture; e--O, 
anti-TNP PFC/culture; A--/k,  cell recovery as per cent of cells present initially. 
TABLE  I 
The Effect of Con A  on Cell Recovery  and Cell  Viability 
Control cultures  Con A stimulated (2 ~g/ml) 
Expt. No. 
Recovery  Viability  Total  Recovery  Viability  Total 
%  %  %  % 
94  57  69  39  77  55  42 
95  52  62  32  73  43  32 
96  57  68  39  74  52  38 
of Con A is shown in Fig. 3. The ability of Con A to inhibit the response was lost 
after only 5 hr of culture. Con A was stimulatory when added at 24 hr. 
Reversal of Con A  Effects with  a-Methyl l~-Mannopyranoside.--The  addition 
of  a-methyl D-mannopyranoside alone to cultures had little effect on the anti- 
SRBC measured at day 4 to concentrations of 10 mg/ml. There was a 50-75 % 
inhibition at 20 mg/ml  (see Fig. 4). Increasing concentrations of the sugar in- 
creasingly suppressed the inhibitory effect of 2/zg of Con A. There was almost ,o 
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Fro. 3. Time of addition of Con A relative to time of antigen addition. In this experiment 
antigen was added  2 hr after the beginning of incubation.  •---  control. 
complete suppression at 10 and 20 mg/ml. The sugar also blocked the stimula- 
tory effect of Con A on Ceil recovery. 
The Effect of Con A  on the Response of Goal-Anli-BA  Thymus Antigen Serum- 
Treated  Spleen  Cell Suspensions.--The  response  of  goat  antiserum-treated 
spleen cell suspensions of normal mice is depressed. The addition of Con A at 
zero time  restores  the  response,  Fig.  5.  The  restoration  of the  response  was 
achieved  by  the  same  concentrations  of  Con  A  that  inhibited  the  normal 
response.  In other experiments higher concentrations of antisera were used in 
the preparation of the treated ceil suspensions  (Fig. 6).  It can be seen that T 
cell "helper" activity was lost at concentrations of antisera that did not prevent 
the restoration seen on adding Con A. 
The Effect  of Con A  on  the Responses  of A TXBM Mice.--The  in  vitro re- 
sponses  of  a  number  of  ATXBM  mice  were  depressed  to  varying  degrees, 
ranging from 90% to no depression at all. The depressed responses were com- 
pletely restored by Con A. In addition,  those ATXBM mice that had no de- 
pression in their response nevertheless  responded differently from normal mice 
in the presence of Con A in that they showed no inhibition at 2 >g/ml, Fig. 7. 
In contrast to all previous effects of Con A, the dose-response curve did not RICHARD  W.  DUTTON  1451 
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FI6.4. Prevention of the effects of Con A with a-methyl D-mannopyranoside. Cell suspen- 
sions from the spleens of normal mice were incubated in the presence or absence of 2 #g/ml 
Con A and varying concentrations  of a-methyl 9-mannopyranoside.  SRBC  were added at 
T  =  0, and the anti-SRBC PFC per culture and the cell recovery, expressed as a per cent of 
the number of cells present initially,  were assayed on day 4. O  -O, PFC response, no Con A; 
A, PFC response +  Con A; O--O, cell recovery, no Con A; A, cell recovery +  Con A. 
show a marked peak of activity at 2 #g/ml. Con A  seemed to be equally effec- 
tive at restoring the ATXBM-depressed responses over a  wide  concentration 
range from 1~  up to 4 #g/m]  (see Fig. 7). The cell recovery was increased  by 
Con A  in three out of four cases. 
The Effect  of Adding  Con A-Treated  Cells  to Normal Cells.--We  have  seen 
above that the same concentration of Con A  that restores the response of goat 
antiserum-treated cells inhibits the response of normal cells. One possible ex- 
planation of this finding was that Con A  stimulated T  cells to produce a factor 
that in low concentrations stimulated the B  cells but in higher concentrations 
was inhibitory. In order to test this, normal spleen cell suspensions were incu- 
bated with inhibitory concentrations of Con A for 48 hr. They were then washed 
twice in BSS and graded numbers of these cells were added to fresh normal cells 
in the absence of Con A. It can be seen from Fig. 8 that even small numbers of 
Con A-stimulated cells inhibited the response of normal cells. Also shown is the 
effect of the addition of cells incubated in the absence of Con A  as a control. 
The Effect of Irradiation on the Inhibitory Effects of Con A.--An  alternative 1452  EFtfECTS  OF  CON  A  ON  THE  I2YIMUNE  RESPONSE 
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FIG. 5. Effect of Con A on the response of goat anti-BA thymus antigen-treated spleen cells. 
Spleen cell suspensions from normal mice were treated with goat antisera to remove T cells 
(see Materials and Methods). Normal and  treated cells were  incubated with SRBC  and 
various concentrations  of Con A added at T  =  0. The anti-SRBC PFC and the cell recovery 
were assayed at day 4 (in this experiment the number of goat antiserum-treated cells was not 
adjusted back up to 1 X  107/ml). O--O, PFC response, normal cells; A  -A, PFC response, 
antiserum treated ceils; I- -0, cell recovery, normal ceils; k- -A, cell recovery, antiserum- 
treated cells. 
explanation  of  the  opposing effects  of  Con  A  was  that  there  were  two  cells 
targets or activities that were responding to the presence of Con A. The effect 
of Con A on the first of these would be the triggering of an inhibitor effect lead- 
ing to the suppression of the B  cells responding to antigen. The second target 
would be a cell that responded to Con A by providing a sfimulatory effect to the 
]3 cells responding to antigen. 
The effect of Con A  on ATXBM  and the loss of the inhibitory effect on pre- 
incubation noted above lends some support to the hypothesis that such mice 
lacked  a  short-lived,  radiosensitive T  cell, mediator  of  the  inhibitory effect, 
but  retained  a  second  cell, mediator  of  the  stimulatory  effect  on  the  B  cell 
response. We therefore tested the effect of irradiation on the Con A-mediated 
effect in  the following manner.  Goat  antiserum-treated  cell suspensions were 
incubated with varying numbers of normal or irradiated normal spleen cells in 
the presence of Con A  at 2 ~g/ml (Fig. 9). The response of the goat antiserum- 
treated cells was restored by the addition of Con A  as seen in previous experi- RICHARD  W.  DUTTON  1453 
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FIG. 6. Titration of the effect of goat anti-BA thymus antigen on the response of spleen cell 
suspensions  to SRBC in the presence (A--z~) and absence (C)--O) of Con A. 
ments. The addition of increasing numbers of normal ceils resulted in increasing 
inhibition of the cultures. When irradiated normal cells were added, however, 
the response of the goat antiserum-treated cells was unaffected. Cell recoveries 
were also measured. In either case there was a marked increase in the cell  re- 
covery which  was  only slightly  greater in  the  presence  of  the  normal  cells. 
Irradiation  thus  blocked  the  inhibitory  effect  of  Con  A-treated  cells.  This 
experiment does not  reveal whether  the  stimulatory effect is radioinsensitive 
since the goat antiserum-treated cells are restored by Con A alone without the 
addition of irradiated normal cells. 
DISCUSSION 
The addition of Con A  to spleen cell cultures of normal mice inhibited the 
response  to  erythrocyte  antigens,  stimulated  the  incorporation  of  tritiated 
thymidine, and led to an increased cell  recovery. The dose-response curve for 
each of these parameters was the same with a narrow peak of activity at 2 #g 
of Con A/ml. Fourfold higher concentrations had less effect while still higher 
concentrations  appeared to be nonspecifically toxic.  It is of interest  that  re- 
sponses to antigen are not inhibited by concentrations of Con A  that are high 
enough to give some inhibition of capping of cell surface immunoglobulins (40). 
The mitogenic effect and the inhibition of the response to antigen could both be 
blocked  by  the  presence  of  sufficient  ~-methyl  D-mannopyranoside.  A  vast 1454  EFFECTS  OF  CON  A  ON  THE  IMMUNE  RESPONSE 
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FIG. 7. Effect of Con A on the response of four ATXBM mice spleens to SRBC. Spleen cell 
suspensions from four individual ATXBM mice were incubated with SRBC and various con- 
centrations of Con A added at T  =  0. The number of PFC/culture and the cell recoveries 
were assayed at day 4. The results obtained with four separate mice are illustrated O, A, 
molecular excess of sugar was needed to achieve a  50%  block (approximately 
2  X  I(F  ~ molecules of sugar, 5  X  10  TM  molecules of Con A  monomer,  and  1014 
Con A  binding sites). The inhibitory effect of Con A  was equally apparent for 
the  response  to  hapten  and  for  the  response  of  spleens  from  carrier-primed 
mice. 
A  number of procedures appeared to remove a cell or cell activity that Con A 
stimulated to produce the inhibitory effect. In the absence of the inhibitory cell 
effect Con A  was seen to stimulate the response to antigen. Thus, if Con A was 
added to the spleens of normal mice after 24 hr preincubation, a twofold stimu- 
lation of the response was routinely observed. The addition of Con A  to spleen 
cells suspensions  treated with  goat  anti-BA thymus  antigen  restored  the  re- 
sponse  to  antigen.  The  dose-response  curve  again  showed  a  sharp  peak  of 
activity  at  2  /zg/ml.  The  response  of  spleen cell  suspensions  from  ATXBM 
mice was restored to above normal values by Con A. It was curious that the 
dose-response curve for this last effect was markedly different in that it did not 
show a narrow peak of activity at 2 ~g/ml  but rather a broad range of activity 
from 0.25 to 4 ~g/ml (Fig. 8). 
The  radiosensitivity of the cell mediating the inhibitory effect was  demon- I0,000 
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FIO. 8. Effect of adding Con A-treated cells to normal mouse spleen cell suspensions. Spleen 
cell suspensions from  the spleens of normal mice were incubated with or without 2 #g/ml 
Con A for 48 hr. They were then washed two times in 10 ml of sterile BSS and resuspended 
in complete medium at 1 X  107/ml. Graded amounts of the resulting suspensions were added 
to  suspensions  of  fresh  normal  mouse  spleens  keeping  the  total  cell  number  constant 
at 1 N  107/ml. SRBC were added at T  =  0 and the anti-SRBC PFC response was measured 
at day 4. Cells preincubated with Con A (O--O) and without  (A--A). 
strated in the experiment where normal or normal, irradiated cells were added 
to goat  anti-BA thymus  antigen-treated cells in  the presence of Con A.  The 
results are compatible with the hypothesis that at least two cells respond to the 
presence of Con A. The first cell, which mediates the inhibitory effect is rapidly 
lost in culture or at least changes in its response to Con A. It is radiosensitive 
and is eliminated by treatment with goat anti-BA thymus  antigen.  Its proper- 
ties are therefore similar to those of T1 cells described by Raft and Cantor (49). 
It may also be the same cell that mediates the Con A-stimulated cytotoxic 
effects  in  the  experiments  of  Stavy  et  al.  (37)  and  of  Ginsburg  et  al.  (38). 
However, Perlmann et al. (50) have shown that Con A-treated human lympho- 
cytes are no longer stimulated to cytotoxic activity by incubation with PHA. 
It is possible that the inhibitory effect of Con A  on the response to antigen is 
not mediated by a cytotoxicity effect but by some other mechanism. 
The inhibitory effect does seem to be mediated by some active process of one 
cell on another since small numbers of Con A-treated cells inhibit the response 
of fresh normal cells (Fig. 8). There is also evidence that the cytotoxic activity 
that is expressed after treatment with mitogens is the property of a different cell 1456 
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FIG. 9. Effect of irradiation on the inhibitory effect of Con A on the response to antigen. 
Spleen cell suspensions from normal mice were treated with goat antisera to remove most T 
cells. The response of the treated cells was restored by the addition of 2/zg/ml Con A. Graded 
numbers of either normal (z~--Z~) or irradiated normal cells (O--O) were added keeping the 
total cell number constant at 1 X  107/ml. SRBC were added at T  =  0 and the anti-SRBC 
response was assayed at day 4. 
from the one that responds by blast transformation and proliferation. Thus, 
in the experiments referred to above (50)  Con A  does not block the prolifera- 
tive response to PHA and Stites et al. (51) have shown that thymus cells of the 
human fetus respond to PHA by proliferation but exhibit no cytotoxic activity 
against xenogeneic cells while the reverse pattern of response was observed in 
cells from fetal bone marrow. In the face of evidence for such extensive hetero- 
geneity in lymphocyte populations it would be unwise to draw an)- firm con- 
clusions as to the nature of the inhibitor cell. 
The second cell cannot be identified on the basis of the data provided in this 
paper. It would appear to replace the function of the helper T  cell in the B cell 
response. Con A does not appear to act directly on B  cells (41).2 It is therefore 
possible that  it is another T  cell which is triggered to produce  a  factor  that 
allows the B  cell to  respond to  antigen but other possibilities cannot be  ex- 
cluded at this time. 
2 Watson,  J.,  R. Epstein, I. Nakoinz, and P. Ralph. The role of humoral factors in the 
initiation  of in vitro primary immune responses.  II. Effects of lymphocyte mitogens. Y. Immunol. 
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SUMMARY 
The  presence  of concanavalin A  (Con A)  inhibits  the  immune  response  of 
mouse spleen cell suspensions to erythrocyte antigens, stimulates the incorpora- 
tion of tritiated  thymidine, and increases cell recovery. Con A  also restores the 
depressed response of cell preparations treated to remove thymus-derived ceils. 
The dose-response curve for all four effects shows peak activity at 2 #g/ml. The 
depressed in vitro response of spleen cell suspensions from adult thymectomized, 
irradiated,  bone  marrow-restored  mice  is  also  restored  by  Con A.  Here  the 
dose-response curve is quite different with activity over a much wider range of 
concentration.  The  restoration  of  thymus-derived  cell-depleted  cultures  by 
Con A is inhibited by the addition of untreated, unirradiated, mouse spleen cell 
suspensions, but is not inhibited by untreated, irradiated cells. 
Small numbers of spleen cells that have been preincubated  with Con A  and 
washed will inhibit the response of fresh, untreated cells to antigen. If the mouse 
spleen cell suspensions are incubated for 24 hr before the addition of Con A, the 
response to antigen is no longer inhibited but is stimulated instead. 
The data are compatible with the hypothesis that there are at least two cell 
targets for the action of Con A. One cell, that mediates the inhibitor effect, is a 
short-lived,  radiosensitive,  thymus-derived cell.  The other cell,  that mediates 
the  stimulating  effect,  cannot be identified  from the data presented  here  but 
may also be of thymus origin on the basis of studies by other investigators. 
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